dc.contributor.author | Repschlaeger, C | en_US |
dc.contributor.author | Odabashian, M | en_US |
dc.contributor.author | Spada, F | en_US |
dc.contributor.author | Almutairi, Z | en_US |
dc.contributor.author | Gribben, JG | en_US |
dc.contributor.author | Forconi, F | en_US |
dc.contributor.author | Sayan, E | en_US |
dc.contributor.author | Alves, AC | en_US |
dc.contributor.author | Giroud, C | en_US |
dc.contributor.author | Fedorov, O | en_US |
dc.contributor.author | Kriajevskaia, M | en_US |
dc.contributor.author | Krysov, S | en_US |
dc.date.accessioned | 2023-03-14T09:38:05Z | |
dc.date.issued | 2022 | en_US |
dc.identifier.issn | 0006-4971 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/84962 | |
dc.format.extent | 12375 - 12376 | en_US |
dc.title | EMT-like Activation in CLL Provides Novel Therapeutic Target | en_US |
dc.type | Conference Proceeding | |
dc.identifier.doi | 10.1182/blood-2022-162696 | en_US |
pubs.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000893230305197&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 140 | en_US |
qmul.funder | A novel B-cell receptor-nuclear repressor ZEB2 axis that defines the clinical outcome in chronic lymphocytic leukaemia::Leuka | en_US |
qmul.funder | A novel B-cell receptor-nuclear repressor ZEB2 axis that defines the clinical outcome in chronic lymphocytic leukaemia::Leuka | en_US |